This program is tailor-made for you if your business is involved in developing medications, particularly for treating Substance Use Disorders. You can access up to $5 million per year to fund your innovative research projects, which can greatly accelerate the process towards FDA approval. This is your chance to bring ideas to life while addressing pressing health issues that impact many individuals.

Imagine the possibilities: funding for both preclinical and clinical studies over a period of up to three years, with hands-on support and guidance from experienced NIDA staff. This means less time worrying about financial constraints and more time dedicated to meaningful research that makes a difference. Plus, being part of this program allows your company to not only grow but also contribute significantly to society.

Application is straightforward, with eligibility that encompasses all types of organizations, regardless of size or revenue. This program removes traditional funding barriers, enabling you to focus on what you do best: innovating and improving lives through medical advancement.

Type of Financing
The financing provided is a cooperative agreement designed specifically for research projects focused on medication development for Substance Use Disorders (SUDs). This funding is large in scale and can provide up to $5 million per year for qualifying projects.

Repayment Terms and Interest Rates
There are no repayment terms or interest rates associated with this funding, as it operates as a grant rather than a loan. This means that you will not need to pay back the amount you receive.

Eligible Expenses
You can use these funds for a variety of expenses related to your research projects, including:

• Personnel costs
• Research supplies
• Equipment and facility use
• Technical assistance
• Direct costs associated with conducting preclinical and clinical studies

Ineligible Expenses
Funds cannot be used towards marketing costs, administrative or indirect costs outside of the research-related expenses, or any personal expenses unrelated to the project.

Fees
There are no hidden fees associated with this program. What you receive is what you can use for your project.

This program enables you to fast-track medication development for treating Substance Use Disorders. You can access funding of up to $5 million per year to support your research projects. This funding can be used for both preclinical and clinical studies aimed at advancing medications towards FDA approval.

The funding aims to support high-impact research that can yield quick results. It's available to all companies, regardless of size or revenue, allowing you the flexibility to innovate without traditional funding barriers. Plus, the program can fund your projects for up to three years, with close monitoring from experienced NIDA staff to ensure effectiveness.

By participating, you can make a significant contribution to addressing critical health issues while securing the resources necessary to pursue your research goals. This is a chance to bring your ideas to life and support those in need by developing medications that can help tackle Substance Use Disorders effectively.